Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) SHH
8.35
+0.18(+2.20%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Henan Taloph Pharmaceutical Stock Co.,Ltd
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2214
First IPO Date
November 05, 1999
Key Executives
| Name | Title | Pay | Year Born |
| Fengshan Su | Executive Vice General Manager | 0 | 1977 |
| Nianyun Li | Deputy GM & Secretary | 0 | 1991 |
| Feng Yun Chen | Accounting Supervisor & Employee Representative Director | 0 | N/A |
| Hailin Zhao | CFO & Deputy GM | 0 | 1975 |
| Lizhuang Zhang | Deputy General Manager | 0 | 1966 |
| Jingliang Li | GM & Vice Chairman | 0 | 1969 |
Description
Henan Taloph Pharmaceutical Stock Co., Ltd. researches, produces, and sells Chinese and western medicines in China. It primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and other forms. The company's principal products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, pazufloxacin mesylate sodium chloride injections, and various infusion products. It serves hospitals, pharmacies, and patients. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co., Ltd. is based in Zhengzhou, China.
